// OUR MISSION
Analytics, tools and data curation solutions to deliver just-in-time pain data at scale.
// OUR PRODUCT PORTFOLIO
At Celéri Health, we specialize in harnessing pain data to transform patient care. Our unique portfolio, built on a proprietary platform, is dedicated to collecting and utilizing pain data. From patient-reported outcomes to the world’s largest pain dataset, we’re revolutionizing pain management and care planning. Discover our innovative products: PainIntel™, PainRWD™, and PainExplorer™.
For Industry & Providers
PainIntel offers advanced analytics capabilities to understand pain patterns and patient responses. By leveraging data-driven insights, this tool aids in personalizing pain management strategies, ensuring each patient receives tailored care based on their unique pain profile.
PainRWD™ Science Cloud
For Life Sciences
The world’s only EHR-derived, novel pain dataset that supports fast RWE insights, R&D intelligence and transformative data science for researchers. Over 100k pain cases with a depth of over 200 data elements per case, including concomitant medications, co-morbid conditions, SDOH and validated PROs such as PROMIS-29, NRS, Oswestry, and more.
PainExplorer™ Research Group
Designed for quick project deployment and high quality data collection, PainExplorer™ ensures compliance and participant management ease. Ideal for multi-indication device studies and dynamic research needs. Leverage support for dynamic visits, biometric data gathering and treatments.
// OUR DISEASE COMMUNITIES
Our Science Cloud contains ready-to-use disease cohorts for collaboration and analysis.
To improve the research and management of pain, a greater understanding is needed on the heterogeneity of patients with pain. Yet old-school epidemiological and clinical research traditionally imposes constraints that prevent us from assessing the holistic view of a patient with pain. Live real-world data changes the game.
“We have a responsibility to enhance the lives of patients coping with pain and we are going to continue to innovate to meet our commitment.” – Celéri Health President and CEO, Sean McCrossen